Railway Pension Investments Ltd lessened its holdings in shares of McKesson Corporation (NYSE:MCK – Free Report) by 8.6% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 126,122 shares of the company’s stock after selling 11,800 shares during the quarter. McKesson makes up about 1.3% of Railway Pension Investments Ltd’s investment portfolio, making the stock its 21st biggest position. Railway Pension Investments Ltd’s holdings in McKesson were worth $92,420,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in MCK. MassMutual Private Wealth & Trust FSB lifted its position in McKesson by 1.6% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 863 shares of the company’s stock worth $632,000 after buying an additional 14 shares during the period. Cardinal Point Capital Management ULC increased its stake in shares of McKesson by 2.2% during the 2nd quarter. Cardinal Point Capital Management ULC now owns 645 shares of the company’s stock valued at $473,000 after acquiring an additional 14 shares during the last quarter. Cypress Wealth Services LLC lifted its holdings in shares of McKesson by 3.7% during the 2nd quarter. Cypress Wealth Services LLC now owns 417 shares of the company’s stock worth $305,000 after acquiring an additional 15 shares during the period. HBK Sorce Advisory LLC lifted its holdings in shares of McKesson by 1.4% during the 2nd quarter. HBK Sorce Advisory LLC now owns 1,182 shares of the company’s stock worth $866,000 after acquiring an additional 16 shares during the period. Finally, Valmark Advisers Inc. boosted its position in shares of McKesson by 2.1% in the second quarter. Valmark Advisers Inc. now owns 843 shares of the company’s stock worth $618,000 after acquiring an additional 17 shares during the last quarter. Hedge funds and other institutional investors own 85.07% of the company’s stock.
Analyst Ratings Changes
Several equities analysts recently commented on the stock. Cowen reaffirmed a “buy” rating on shares of McKesson in a research report on Wednesday, September 24th. Wells Fargo & Company boosted their price objective on shares of McKesson from $816.00 to $914.00 and gave the company an “equal weight” rating in a research note on Monday, November 10th. UBS Group increased their target price on McKesson from $920.00 to $980.00 and gave the stock a “buy” rating in a research report on Thursday, November 6th. Citigroup boosted their price target on McKesson from $820.00 to $860.00 and gave the company a “buy” rating in a research report on Wednesday, September 24th. Finally, Weiss Ratings reiterated a “buy (a-)” rating on shares of McKesson in a report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, McKesson has an average rating of “Moderate Buy” and a consensus price target of $887.69.
McKesson Stock Down 0.5%
MCK opened at $879.00 on Friday. The firm’s 50 day moving average is $807.11 and its 200-day moving average is $741.23. McKesson Corporation has a 52-week low of $558.13 and a 52-week high of $895.58. The firm has a market capitalization of $108.49 billion, a P/E ratio of 35.05, a P/E/G ratio of 1.46 and a beta of 0.51.
McKesson (NYSE:MCK – Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $9.86 EPS for the quarter, topping analysts’ consensus estimates of $8.84 by $1.02. The firm had revenue of $103.15 billion for the quarter, compared to analyst estimates of $103.80 billion. McKesson had a net margin of 0.84% and a negative return on equity of 196.66%. The firm’s revenue was up 10.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $7.07 EPS. Equities analysts expect that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.
McKesson Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be issued a dividend of $0.82 per share. The ex-dividend date is Monday, December 1st. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson’s payout ratio is currently 10.21%.
Insider Activity
In other news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the stock in a transaction that occurred on Friday, November 7th. The stock was sold at an average price of $861.63, for a total transaction of $283,476.27. Following the completion of the transaction, the chief accounting officer directly owned 328 shares in the company, valued at approximately $282,614.64. This represents a 50.08% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.08% of the stock is currently owned by insiders.
McKesson Company Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Articles
- Five stocks we like better than McKesson
- Why Invest in High-Yield Dividend Stocks?
- Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care
- Growth Stocks: What They Are, Examples and How to Invest
- SoFi Technologies: From Fintech Speculation to Profit Engine
- 3 Dividend Kings To Consider
- Gold to $5,000? What Bank of America and UBS Have to Say
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
